| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
54,151 |
49,409 |
$2.20M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
33,599 |
31,574 |
$1.59M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,400 |
5,361 |
$278K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,743 |
8,111 |
$277K |
| S9083 |
Global fee urgent care centers |
7,106 |
6,390 |
$275K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
31,658 |
28,497 |
$147K |
| 99000 |
|
426 |
385 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
115 |
109 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,622 |
1,562 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,137 |
2,997 |
$1K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
97 |
91 |
$645.60 |
| 87070 |
|
3,338 |
3,178 |
$568.28 |
| 81002 |
|
4,967 |
4,826 |
$435.86 |
| 87088 |
|
698 |
683 |
$90.48 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
245 |
240 |
$78.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
134 |
132 |
$32.20 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
231 |
225 |
$12.76 |
| 99072 |
|
150 |
148 |
$12.00 |
| 81025 |
|
15 |
15 |
$2.77 |
| 99383 |
|
17 |
17 |
$0.00 |
| 93000 |
|
12 |
12 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
407 |
397 |
$0.00 |
| 69210 |
|
27 |
26 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
559 |
541 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
85 |
85 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
13 |
13 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
73 |
73 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14 |
14 |
$0.00 |